That finding was supported by the significantly greater probability of achieving MADRS response compared with the low baseline anxiety subgroup; the effect of baseline anxiety on remission rates in venlafaxine extended release-treated patients approached significance.
← all excerpts
Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.
1
—
—